Successful Landing of New Drug R&D Cooperation: Formulation Development Entrusted by biotech company from Taiwan

Fuzhou SASAC Party Secretary and Director Weng Guoping Leads Delegation to LBE Pharma for Research and Guidance, Praising Hard Core Technology in Advanced Drug Formulations

On the morning of May 13, 2026, Weng Guoping, Party Secretary and Director of th

Fujian Provincial Medical Products Administration Deputy Director Yu Hua Leads Delegation to LBE Pharma for Research and Guidance, Discussing Cross-Strait Pharmaceutical Integration and Development

On May 11, 2026, Yu Hua, Member of the Party Leadership Group and Deputy Directo

Pingtan People’s Congress Working Committee Delegation Led by Secretary Chen Shiqiang Visits LBE Pharma for Research and Inspection

On the morning of November 7, 2025, Chen Shiqiang, Secretary of the Party Leader

LBE Pharma Awarded ISO 9001:2015 Quality Management System Certification

Recently, LBE Pharma successfully passed the rigorous audit of its quality manag

Successful Conclusion｜LBE Pharma Unveils a New Chapter in Precision Drug Delivery and CDMO Excellence

Frankfurt, Germany – October 30, 2025The three-day CPHI Europe 2025 wrapped up s

LBE Pharma Invites You to CPHI Worldwide 2025 – The 33rd CPHI World Pharmaceutical Ingredients Europe

From October 28th to 30th, 2025, LBE Pharma will be exhibiting at CPHI Worldwide in Frankfurt, Germany. We look forward to sharing our innovations and exploring international cooperation opportunities with partners and industry peers on-site.

Fujian Hometown Camp of ACTA Taiwanese Compatriots Youth Summer Camp Visits LBE Pharma: Exploring a New Chapter of Cross-Strait Integration with High-End Pharmaceutical Formulations as a Bridge

On September 4, a delegation of Taiwanese youth from the 'Fujian Hometown Camp'

The Dual-Chamber Revolution: Redefining Drug Delivery for Patients and Pharma

01 From Complex Treatment to Patient-Friendly TherapyOver recent decades, the ra